SCHEMBL17048404

SCHEMBL17048404

[c]1nc(-c2cc[nH]n2)cc2ccccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9870201 0.83 ALDH1A1 (0.35)
SCHEMBL637345 0.72 MEN1 (0.43)
SCHEMBL5595305 0.71 KDM4E (0.52)
SCHEMBL6247283 0.70 KDM4E (0.41)
SCHEMBL78634 0.70 RAB9A (0.44)
SCHEMBL2034106 0.70 MAPT (0.35)
SCHEMBL1673128 0.69
SCHEMBL115772 0.69 NPC1 (0.34)
SCHEMBL6773803 0.69 NTRK1 (0.30)
SCHEMBL10915970 0.69 ESR1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3303335-B1 HETEROCYCLIC COMPOUNDS FOR TREATING PSORIASIS JS INNOPHARM SHANGHAI LTD (CN) 2021-07-28 EP disclosed
EP-3337787-B1 1H-PYRAZOLO[3,4-B]PYRIDINE, 1H-THIENO[2,3-C]PYRAZOLE AND 1H-INDAZOLE CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS EXTRACELLULAR SIGNAL-REGULATED KINASES (ERK) INHIBITORS FOR TREATING CANCER JS INNOPHARM SHANGHAI LTD (CN) 2021-03-03 EP disclosed
EP-3110815-B1 INDOLOQUINOLONE COMPOUNDS AS ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS JIANGSU ASCENTAGE BIOMED DEV INC (CN) 2020-02-19 EP disclosed
EP-3110815-A1 INDOLOQUINOLONE COMPOUNDS AS ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS Jiangsu Ascentage Biomed Development Inc. (CN) 2017-01-04 EP disclosed
WO-2015127629-A1 INDOLOQUINOLONE COMPOUNDS AS ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS JIANGSU ASCENTAGE BIOMED DEVELOPMENT INC. (CN) 2015-09-03 WO disclosed